2026-01-23 - Analysis Report
## Stock Analysis Report: Lam Research Corporation (LRCX)

### Company Overview
Lam Research Corporation is a leading provider of semiconductor processing equipment and services.

### Return Rate Comparison and Cumulative Returns

* Cumulative Return of Review Stock (LRCX): **307.92%**
* Cumulative Return of Comparison Stock (S&P 500, VOO): **92.53%**
* Divergence (Current): **221.80**
* Divergence (Relative): **100.00%**

Lam Research Corporation has significantly outperformed the S&P 500 in the provided data.

### Alpha, Beta Analysis
```markdown
| Year     | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018 | 0.0% | 34.0% | -5.0% | 1.6 | 17.2B |
| 2017-2019 | 38.0% | 34.0% | 20.0% | 1.7 | 36.9B |
| 2018-2020 | 57.0% | 34.0% | 36.0% | 1.5 | 59.5B |
| 2019-2021 | 105.0% | 24.4% | 62.0% | 1.6 | 90.7B |
| 2020-2022 | -10.0% | 49.0% | -8.0% | 1.6 | 53.0B |
| 2021-2023 | -13.0% | 49.0% | -14.0% | 1.8 | 98.8B |
| 2022-2024 | -46.0% | 42.4% | -66.0% | 1.9 | 91.1B |
| 2023-2025 | 149.0% | 43.7% | 87.0% | 2.0 | 215.9B |
```
The CAGR values indicate a strong growth trend, with some fluctuations in MDD and Alpha.

### Recent Stock Price Fluctuations

* Close: **$220.70**
* Last-Market: **-3.37**
* 5-Day SMA: **$222.39**
* 20-Day SMA: **$200.80**
* 60-Day SMA: **$172.41**

The stock has experienced a moderate decline in recent days.

### RSI, PPO, and Delta Prevalent Analysis:
```markdown
- Market Risk Indicator (MRI): 0.90
- RSI: 74.46
- PPO: 0.34
- Recent (20 days) relative divergence change: 0.00
- 7-day Dynamic Expected Return change: -0.60
- Expected Return: 11.10%
```
The stock has a high risk indicator and a relatively high expected return, but a sharp decline in the recent 20-day period.

### Recent News and Significant Events

* [2026-01-22] Lam Research (NASDAQ:LRCX) Stock Price Up 2.7% - Still a Buy?
* [2026-01-20] Is It Too Late To Consider Lam Research (LRCX) After A 176% One Year Surge?
* [2026-01-22] LRCX: Citigroup Raises Price Target for Lam Research Amidst Main
* [2026-01-22] Lam Research stock swings lower after early pop as Citi, Deutsche Bank lift targets ahead of earnings
* [2026-01-22] Lam Research rises as Citi ups target on more wafer equipment upside
* [2026-01-22] Can Lam Research (LRCX) Turn Tariff Uncertainty Into an Edge in AI Chip Equipment?

### Analyst Opinions:
```text
Analyst Consensus:
    - Key: Buy
    - Mean (1=StrongBuy~5=Sell): 1.72 (Buy)
    - Opinions: 31
    - Target Price (avg/high/low): 206.13 / 265.00 / 115.00
```
Analysts are overall positive on the stock.

### Recent Earnings Analysis
```markdown
| Date     | EPS | Revenue |
|----------|-----|---------|
| 2025-10-24 | 1.24 | 5.32 B$ |
| 2025-04-25 | 1.04 | 4.72 B$ |
| 2025-01-31 | 0.93 | 4.38 B$ |
| 2024-10-28 | 0.86 | 4.17 B$ |
```
The company has shown a trend of increasing revenue and EPS.

### Financial Information: Revenue and Profitability
```markdown
| Quarter        | Revenue | Profit Margin |
|----------------|----------|---------------|
| 2025-09-30    | $5.32B | 50.43% |
| 2025-06-30    | $5.17B | 50.08% |
| 2025-03-31    | $4.72B | 49.02% |
| 2024-12-31    | $4.38B | 47.37% |
| 2024-09-30    | $4.17B | 48.05% |
```
The company has consistently maintained a high profit margin.

### Financial Information: Capital and Profitability
```markdown
| Quarter        | Equity | ROE |
|----------------|---------|-----|
| 2025-09-30    | $10.19B | 15.39% |
| 2025-06-30    | $9.86B  | 17.44% |
| 2025-03-31    | $9.51B  | 13.99% |
| 2024-12-31    | $8.81B  | 13.52% |
| 2024-09-30    | $8.47B  | 13.18% |
```
The company has consistently shown strong equity growth and increasing ROE.

### Comprehensive Analysis

Based on the provided data, Lam Research Corporation has shown a strong growth trend, with a high expected return but a relatively high risk indicator. The company has consistently maintained a high profit margin and has shown strong equity growth and increasing ROE. However, the stock has experienced a moderate decline in recent days, and the recent 20-day period has shown a flat relative divergence change. Overall, the stock may be considered a buy, but investors should exercise caution due to the high risk indicator.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.